You are here: Industry Insights > Acquisition

News List

Gilead to acquire stake in Tizona Therapeutics for $300n pharmaceutical-technology
July 23, 2020
Gilead Sciences is set to acquire a 49.9% equity interest in cancer immunotherapies maker Tizona Therapeutics through an investment of $300m.
Nexelis Acquires AIT Bioscience contractpharma
July 23, 2020
AIT Bioscience’s advanced testing capacity bolsters service offering in the bioanalytical segment.
Mydecine Innovations, NeuroPharm Sign Acquisition Agreement americanpharmaceuticalreview
July 22, 2020
Mydecine Innovations has entered into a definitive share exchange agreement for the acquisition of 100% of NeuroPharm, a Canadian-based developer of natural psychedelic-based treatments for mental health disorders in the Canadian and United States ...
Grifols to acquire GC Pharma’s plasma fractionation facility for $460m pharmaceutical-technology
July 22, 2020
Plasma-derived medicines company Grifols has executed purchase arrangements with South Korean-based GC Pharma to acquire a plasma fractionation facility in Montreal, Canada for $460m.
Cytocom Acquires ImQuest Life Sciences contractpharma
July 21, 2020
Gains ImQuest Pharmaceuticals, BioSciences, and Life Sciences divisions, adding drug development and CRO ops, and pipeline assets.
Amgen makes $421m additional investment in BeiGene pharmaceutical-technology
July 15, 2020
Amgen has made an additional investment of approximately $421m to the registered direct offering of ordinary shares of Chinese biotechnology firm BeiGene.
ABITEC Acquires Larodan AB Research Grade Lipids americanpharmaceuticalreview
July 10, 2020
ABITEC Corporation has acquired Larodan AB, a manufacturer and international marketer of high-purity research grade lipids. This strategic acquisition will expand ABITEC’s functional lipid product offerings and scientific capabilities.
LGC Acquires The Native Antigen Company contractpharma
July 10, 2020
NAC was one of the first companies globally to offer antigens for SARS-COV-2 and continues to support the global response to the COVID-19 pandemic.
Healthcare industry reports deals worth US $8.2-bn in June’20: GlobalData expresspharma
July 09, 2020
In June 2020, the healthcare industry reported 87 deals worth US $8.2 billion as compared to last 12 months’ average (June 2019 to May 2020) of 64 deals worth US$17.7 billion.
Frontage Acquires ACME Bioscience contractpharma
July 09, 2020
Expands synthetic and medicinal chemistry and process research and development services.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page